Abstract
Background and purposeVariability in response to the P2Y12 receptor antagonists administered to patients with cerebral aneurysms treated with the Pipeline Embolization device (PED) or stents may play an important role...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
